Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,242
+$2,682 QoQ
Shares Held
37,523
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 72 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 62%
Shared 38%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sculptor Capital LP holds $612,815 across 3 Drug Manufacturers - Specialty & Generic names. ALVO ranks #3 (0.9% of the industry book) .
All Filings in ALVO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,242 | 33,821 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,560 | 33,821 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,895 | 33,821 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $276,993 | 33,821 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $372,196 | 40,811 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $394,641 | 40,811 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,019,627 | 606,170 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,246,666 | 945,098 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,492,391 | 945,098 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,782,098 | 1,946,162 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,471,263 | 1,086,347 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,907,484 | 1,086,347 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,408,325 | 1,086,347 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,013,876 | 1,086,347 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $10,863,470 | 1,086,347 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,343,705 | 1,086,347 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,747,000 | 700,000 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||